Barbara Peterlin
Neurology · East Syracuse, NYNPI 1780664292
Payments from drug & device makers
Across 594 payments — averaging $1024.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$285K
- Lundbeck LLC$165K
- Amgen$75K
- Impel Pharmaceuticals Inc.$30K
- Biohaven Pharmaceutical Holding Company Ltd.$28K
- Biohaven Pharmaceuticals, Inc.$26K
- plus $159 from 5 others
What the payments were for
- Consulting fees$43,1867%
- Speaking & faculty fees$536,42088%
- Travel & lodging$15,8523%
- Food & beverage$13,0692%
- Education$630%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 293 | $284,529 |
| Lundbeck LLC | 157 | $165,010 |
| Amgen | 70 | $75,217 |
| Impel Pharmaceuticals Inc. | 22 | $29,548 |
| Biohaven Pharmaceutical Holding Company Ltd. | 25 | $27,940 |
| Biohaven Pharmaceuticals, Inc. | 19 | $26,187 |
| Novartis | 3 | $78 |
| Acorda Therapeutics, Inc | 1 | $24 |
| Zyla Life Sciences, Inc. | 2 | $22 |
| Lilly USA, LLC | 1 | $21 |
| UCB, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$608,590 in reported general payments places this provider in the 90th percentile of 1,623 neurology providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| UbrelvyUbrogepant | 11 | $16,950 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieUbrelvy | $284,529 | $16,95011 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,623 neurology providers in New York.
Other neurology in East Syracuse
- Christian GrommesNew York$9.9M
- Ilya KisterNew York$9.5M
- E DorseyNew York$8.5M
- Lauren SchaffNew York$8.2M
- Richard HolubAlbany$6.3M
- Martin SadowskiNew York$5.4M
- Lawrence HonigNew York$4.9M
- Laszlo MechtlerAmherst$4.3M
- Bennett MyersAmherst$3.8M
- Krupa PandeyAlbany$3.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.